📋 Trade Summary Setup: Price bouncing off ascending trendline support in a tightening triangle pattern. Entry: Market buy at ~$340 Stop-loss: Below channel support at $327.74 Targets: Initial: $355 (trendline break) Main: $388.75 (analyst price target) Risk/Reward: ~1:3 R/R 🔎 Technical Rationale Trendline Support: Price is...
Trade Summary 📝 Setup: KNX building higher lows above rising support; testing multi-month resistance zone. Entry: Watching for long entry on a break above $46.26. Stop-loss: Below $44.20 (just under trendline support). Targets: $49 (near double top resistance), $52.32 (analyst price target). Risk/Reward: Attractive with defined risk and upside...
Trade Summary 📝 Setup: Channel squeeze at multi-week support; volatility contracting. Entry: Entering at market (current price ~$56.34), bottom of channel. Stop‑loss: $55.50 (tight stop under structure). Targets: $62 (channel top), $70+ (gap area), $85.27 (analyst 1-year target). Risk/Reward: Strong; defined risk, multi-level upside. Technical...
Trade Summary 📝 Setup: Descending wedge forming after sharp drop; price testing breakout line. Entry: Above $240. Stop‑loss: Below $220 swing low/support. Targets: $260 , $293–$301 (analyst target). Risk/Reward: ~3:1 (tight stop, multi-level upside). Technical Rationale 🔍 Key Signal #1: Descending wedge/bullish reversal pattern; oversold...
🔹 Trade Summary Setup: Ascending triangle forming over several months Price consolidating near major resistance Strong analyst buy rating with 1-year target at $203.94 Entry: Buy on daily close above $169.42 (breakout trigger) Stop-loss: Below $159 (invalidate the setup) Targets: $203.94 (analyst target / recent highs) Risk/Reward: ...
🔹 Trade Summary Setup: Price pulling back to ascending trendline support Testing major support near $2.58 Analyst 1-year target: $3.76 Entry: Above today's high of $2.64 (on confirmation of bounce from trendline) Stop-loss: Below $2.40 (clear break of trendline) Targets: $3.76 (analyst price target / major resistance) Risk/Reward: ...
Looking to enter long on a clear breakout above $70.13 (today’s high). • Entry: Above $70.13 • Stop-Loss: Below today’s low (~$68.50) to protect capital • Target: $90.35 – per analyst consensus (~+30%) ✅ Why: 📈 Trendline bounce & momentum: Price holding strong above an ascending trendline from April suggests buyers are stepping in. 🏢 AI-chip catalyst: Marvell’s...
🎯 Trade Setup Overview Entry: Market at Open Stop‑Loss: Below the trendline at ~$9.00 Primary Target: $14.60–$15.50 (analyst zone + historical highs) Reward/Risk: ~50–60% upside vs ~7–10% downside = solid R:R ~5:1 📈 Technical Rationale The stock recently bounced off a long‑term ascending trendline, confirming it as key support. A breakout above ~$10.40 would...
Axsome Therapeutics (AXSM) has just broken out of a multi-month descending trendline, signaling renewed bullish momentum. I will buy at the open, targeting the analyst price target of $176.68 for a potential strong upside move. My stop will be set just below the prior resistance line (~$110), which should now act as support. This setup offers a favorable...
Catalyst Pharmaceuticals (NASDAQ: CPRX) remains poised at the lower trendline of a well-defined ascending channel, trading in the $20.60–$21.00 area. The setup to monitor now is a daily close above $22.10, which would signal a real breakout through the $21.82–$22.11 resistance zone. A decisive push above that level opens the door for a test of the channel’s upper...
The eVTOL space is lighting up today, ACHR included. Shares have rallied ~7%, tapping into a bullish breakout off its ascending triangle and challenging its descending resistance (see chart). Analyst ratings lean strong‑buy, and technicals support further gains. 📈 Why the excitement? A Trump executive order is fast‑tracking drone and air taxi regulations,...
Kura Oncology (KURA) is emerging from a prolonged downtrend just as its lead drug candidate, ziftomenib, approaches a critical FDA decision deadline this fall. With zeroed-in focus on targeted leukemia treatments and no approved competitors in its niche, Kura is positioned to benefit from increasing demand for precision oncology therapies and growing biotech...
Delcath Systems (DCTH) has pulled back to a key long-term support trendline after a sharp correction, presenting an exciting opportunity for a powerful rebound. The stock has respected this rising support for over a year, and buyers have historically stepped in at this level. With the analyst price target set much higher at $24.29, risk/reward here is highly...
KALA BIO (KALA) is forming a bullish ascending channel after a prolonged base, with price consistently making higher lows and higher highs. The current setup suggests strong accumulation, and the stock is now approaching a potential breakout point. A clear uptrend channel is visible, and a breakout from this pattern could trigger a powerful move towards the...
Bitcoin Depot Inc. (BTM) is setting up for a potentially explosive move as price action consolidates within a tightening triangle pattern. After a strong rally from mid-May, BTM found consistent support along an ascending trendline, recently bouncing and holding above this key area. Currently, price is pressing up against a well-defined descending breakout line....